Division of Strategic Planning and Evaluation FY2021 List of Projects - Research Program on Emerging and Re-emerging Infectious Diseases
| First Year | Final Year | Principal Investigator | Affiliation | Project Title | |
|---|---|---|---|---|---|
| FY2019 | FY2021 | SHIMOJIMA Masayuki | National Institute of Infectious Diseases | Chief | Research on diagnosis, treatment, and preventive measures of emerging and re-emerging infectious diseases including viral hemorrhagic fevers |
| FY2019 | FY2021 | SAIJO Masayuki | National Institute of Infectious Diseases | Director | Development of preventive measures of severe fever with thrombocytopenia syndrome (SFTS) |
| FY2019 | FY2021 | NAKAJIMA Noriko | National Institute of Infectious Diseases | Chief | International collaborative research on diagnosis and treatment based on clinicopathological study of severe respiratory infections including novel influenza |
| FY2019 | FY2021 | HASEGAWA Hideki | National Institute of Infectious Diseases | Director | Establishment of fundamental technologies for clinical use of an intranasal influenza vaccine |
| FY2019 | FY2021 | SHIMIZU Hiroyuki | National Institute of Infectious Diseases | Chief | Study of the development of diagnostic, therapeutic, and preventive strategies for emerging and re-emerging enterovirus infections |
| FY2019 | FY2021 | ARITA Minetaro | National Institute of Infectious Diseases | Senior research scientist | Development of poliovirus neutralization test with poliovirus pseudovirus |
| FY2019 | FY2021 | MORI Yoshio | National Institute of Infectious Diseases | Chief | Study to strengthen the surveillance for measles and rubella |
| FY2019 | FY2021 | KIDOKORO Minoru | National Institute of Infectious Diseases | Chief | Study on the development of safe and effective novel mumps vaccines based on both long-term and short-term viewpoint |
| FY2019 | FY2021 | MATSUOKA Masao | Kumamoto University | Professor | Predictive strategy of HTLV-1-associated diseases based on host/viral genomic data and development of an integrated database of clinical and genomic Information |
| FY2019 | FY2021 | TAMURA Toshiki | National Institute of Infectious Diseases | Laboratory Head | Development of new tools to detect latent TB and high-risk individuals, effective recombinant BCG vaccine and booster vaccine, and new drugs for treatment of multidrug resistant tuberculosis, for global tuberculosis control |
| FY2019 | FY2021 | KEICHO Naoto | The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association | Vice Director | Study on biological factors for prediction of disease risk and shorter treatment of tuberculosis |
| FY2019 | FY2021 | SAITO Masuyoshi | Tokyo Medical University | Assistant Professor | Research and development contributing to rapid diagnosis of syphilis |
| FY2019 | FY2021 | MURATA Takeshi | Chiba University | Professor | Development of new antibacterial drug targeting V-ATPase in Vancomycin-resistant Enterococcus (VRE) |
| FY2019 | FY2021 | SUZUKI Masato | National Institute of Infectious Diseases | Senoir Reseacher | Development of novel antibacterial agents by reevaluating old antibiotics and repositioning approved drugs |
| FY2019 | FY2021 | KOHNO Shigeru | Nagasaki University | President | Developmental study of innovative diagnostics and therapeutics against invasive fungal infections, including management of antifungal resistance |
| FY2019 | FY2021 | MARUYAMA Haruhiko | University of Miyazaki | Professor | Development of optimal medical care network for the diagnosis, treatment, and prevention for tropical and parasitic diseases in Japan |
| FY2019 | FY2021 | HISAEDA Hajime | National Institute of Infectious Diseases | Director | Analyses of CNS pathogenesis by parasites and its application to diagnostic and therapeutic strategies |
| FY2019 | FY2021 | MORIKAWA Shigeru | Okayama University of Science | Professor | Studies on examination, diagnosis and prevention methods that contribute to control of zoonoses |
| FY2019 | FY2021 | MATSUMOTO Koji | Showa University School of Medicine | Professor | Study for monitoring the impact of a national HPV vaccination program in Japan (MINT study II) |
| FY2019 | FY2021 | SUGA Shigeru | National Hospital Organization Mie National Hospital | Vice Director | Research on vaccine effectiveness and safety in widely vaccinated population and evaluation and development of vaccine |
| FY2019 | FY2021 | ISHII Koji | National Institute of Infectious Diseases | Director | Study of the development and improvement of quality control of vaccines for various infectious diseases |
| FY2019 | FY2021 | ATO Manabu | National Institute of Infectious Diseases | Director | Study of antitoxin/antivenom therapy and replacement for humanized monoclonal antibodies |
| FY2019 | FY2021 | MURAMATSU Masamichi | National Institute of Infectious Diseases | Director | Establishment of infection systems for viruses that are difficult to replicate in vitro and in vivo, and its application to the development of novel diagnosis, treatment and prevention methods |
| FY2019 | FY2021 | KURODA Makoto | National Institute of Infectious Diseases | Director | Study of development of genome-based comprehensive and rapid pathogen detection system |
| FY2019 | FY2021 | SUZUKI Tadaki | National Institute of Infectious Diseases | Chief | Development of pathological diagnostic methods for congenital infections and unexplained illness of possible infectious etiology |
| FY2019 | FY2021 | KAWAGUCHI Yasushi | The University of Tokyo | Professor | Establishment of novel methods for decoding viral protein coding genes |
| FY2019 | FY2021 | NAKAHARA Tomomi | National Cancer Center | Staff scientist | Development of genome editing based therapy of papillomavirus infected lesions with all in one adenovirus vectors expres sing super multicopy guide RNA and Cas9 nickase |
| FY2019 | FY2021 | SAITO Shinji | National Institute of Infectious Diseases | Postdoctoral fellow | Escape mechanism of influenza virus from anti-HA stem antibody and the application of escape mutant viruses |
| FY2019 | FY2021 | FURUSE Yuki | Kyoto University | Project Assistant Professor | Epidemiological and virological study of severe RS virus infection |
| FY2019 | FY2021 | Moi Meng Ling | Nagasaki University | Associate Professor | Study of neutralizing antibody repertoire in modulating dengue protection for vaccination strategies |
| FY2020 | FY2022 | YASUDA Jiro | Nagasaki University | Professor | Studies on prevention, diagnostics and treatments for viral hemorrhagic fevers by collaborations between industry and academia |
| FY2020 | FY2022 | KAWAOKA Yoshihiro | The University of Tokyo | Professor | Development of next generation Ebola virus vaccines |
| FY2020 | FY2022 | KUTSUNA Satoshi |
National Center for Global Health and Medicine |
Chief, Division of Preparedness and Emerging Infections | Research on the establishment of a treatment and prevention system for Ebola hemorrhagic fever in Japan |
| FY2020 | FY2022 | KAGEYAMA Tsutomu |
National Institute of Infectious Diseases | Head | Study of improvement and practical application of rapid diagnosis of emerging respiratory viral infections |
| FY2020 | FY2022 | WATANABE Shinji |
National Institute of Infectious Diseases | Laboratory Chief | Establishment of a prediction method for seasonal influenza viruses based on their structure, antigenicity, and genetic information and its use for vaccine candidate selection |
| FY2020 | FY2022 | KAWASHIMA Hisashi |
Tokyo Medical University | Professor | Clinical and basic studies on pathophysiology of serious conditions of RS virus infection |
| FY2020 | FY2022 | MURAKAMI Koichi |
National Institute of Infectious Diseases | Division Head | Study of comprehensive molecular epidemiology, prediction, and inapparent infection of viral diarrhea |
| FY2020 | FY2022 | SOMEYA Yuichi |
National Institute of Infectious Diseases | Chief | Virological and structural biological studies of diarrheal viruses for understanding mechanisms of viral replication and pathogenesis |
| FY2020 | FY2022 | KIYONO Hiroshi |
The University of Tokyo | IMSUT Distnguished Professor | Development of new generation mucosal prophylaxis and therapy against diarrheal viruses |
| FY2020 | FY2022 | Chang-Kweng Lim | National Institute of Health | Chief, Laboratory of Arboviruses | Development research to contribute for comprehensive measures of Japan to control the current global epidemic of insect-borne virus diseases |
| FY2020 | FY2022 | HAMAGUCHI Isao |
National Institute Infectious Diseases | Director | Study of comprehensive effective strategy for HTLV-1 infection prevention |
| FY2020 | FY2022 | MATANO Tetsuro |
National Institute of Infectious Diseases | Director | Study for HTLV-1 vaccine development with elucidation of the HTLV-1 control mechanism |
| FY2020 | FY2022 | UCHIMARU Kaoru |
The University of Tokyo | Professor | Development of risk stratification and prevention for HTLV-1-associated diseases based on multi- omics database |
| FY2020 | FY2022 | KATO Seiya |
Research Institute of Tuberculosis, Japan Anti- Tuberculosis Association |
Director | Study of domestic tuberculosis control toward low incidence situation |
| FY2020 | FY2022 | TUYUGUCHI Kazunari |
National Hospital Organization Kinki-Chuo Chest Medical Center | Director | Study of innovative treatment strategy and ideal medical system for intractable and multidrug- resistant tuberculosis |
| FY2020 | FY2022 | ATO Manabu |
National institute of infectious diseases | Director | Study to develop prevention, diagnosis, and treatment of non-tuberculous mycobacterium diseases based on surveillance, genoume database,and clinical information |
| FY2020 | FY2022 | IKEBE Tadayoshi |
National Institute of Infectious Diseases | Senior researcher | Study on pathogenesis of streptococcal toxic shock syndrome and development of new therapeutics |
| FY2020 | FY2022 | KURODA Makoto |
National Institute of Infectious Diseases | Director | Research on development of AMR monitoring systems to hospital sewage, and social implementation of treatment system to reduce its environmental burden. |
| FY2020 | FY2022 | SUGAI Motoyuki |
National Institute of Infectious Diseases | Director | Development of Integrated Surveillance for Antimicrobial Resistance |
| FY2020 | FY2022 | YANAGIHARA Katsunori |
Nagasaki University | Professor | Study of diagnosis and therapy for antimicrobial resistance |
| FY2020 | FY2022 | Longzhu Cui | Jichi Medical University | Professor | Development of novel genetic testing, genotyping and therapeutic methods for implementing effective countermeasure against drug-resistant bacteria |
| FY2020 | FY2022 | MIYAZAKI Yoshitsugu |
National Institute of Infectious Diseases | Director | Investigation of breakthrough innovation for prevalence, novel diagnosis and treatment to overcome the invasive fungal infection by yeasts |
| FY2020 | FY2022 | HISAEDA Hajime |
National Institute of Infectious Diseases | Director | Research for surveillance and risk factors for domestic parasitic diseases |
| FY2020 | FY2022 | YAMAMOTO Masahiro |
Osaka University | Professor | Co-innovative Research and Development to Comprehend and Control Domestic Toxoplasmosis in Japan |
| FY2020 | FY2022 | NOZAKI Tomoyoshi |
The University of Tokyo, Graduate School of Medicine | Professor | Drug and vaccine development against parasitic diseases endemic in Japan |
| FY2020 | FY2022 | OHNISHI Makoto |
National Institute of Infectious Diseases | Deputy Director General | Study of Establishment of Laboratory Response Network among The Research Institutions for Infectious Diseases in Asian Countries |
| FY2020 | FY2022 | NISHIURA Hiroshi |
Hokkaido University | Professor | Study of expanding the use of mathematical models in infectious disease interventions |
| FY2020 | FY2022 | TAKAHASHI Yoshimasa |
National Institute of Infection Diseases | Director | Research and development of novel vaccines and therapeutics for influenza and rabies. |
| FY2020 | FY2022 | OSHIUMI Hiroyuki |
Kumamoto University | Professor | Study of development of small extracellular vesicle–based vaccine |
| FY2020 | FY2022 | YANAGIHARA Itaru |
Osaka Women's and Children's Hospital | Department Head | Study of a novel strategy for controlling preterm birth associated bacteria by using its bacterial restriction-modification system and the development of high sensitive bacterial nucleic acid amplification. |
| FY2020 | FY2022 | OKAMOTO Toru |
Osaka University | Professor | Development of anti-flavivirus compounds by targeting virus-specific life cycles. |
| FY2020 | FY2022 | KUNISAWA Jun |
National Institutes of Biomedical Innovation, Health and Nutrition | Director | Antibody library system for the design of vaccine, drug, and diagnosis and for the functional analysis of pathogens |
| FY2020 | FY2022 | SATO Kei | The University of Tokyo | Associate Professor | Comprehensive survey of infectious microorganisms and the investigation of host responses against microorganism infections |
| FY2020 | FY2022 | NAKANO Satoshi |
Kyoto University | Assistant professor | Molecular characterization and genetic evolution of invasive and non-invasive pneumococcal strains recovered in Japan: the associations of genetic characteristics with disease severity |
| FY2020 | FY2022 | RIMBARA Emiko |
National Institute of Infectious Diseases | Senior Researcher | Non-Helicobacter pylori Helicobacter infections and their roles in human gastric disease |
| FY2020 | FY2022 | MURAKAMI Kosuke |
National Institute of Infectious Diseases | Senior Staff Researcher | Trial to develop a high-performance human norovirus cultivation system based on human intestinal organoids. |
| FY2021 | FY2023 | TAKAHASHI Hitoshi | National Institute of Infectious Diseases | Senior Research Scientist | Study on cell-based influenza vaccine |
| FY2021 | FY2023 | MURAKAMI Shin | University of Tokyo | Associate Professor | Study of preparedness for new MERS-like coronavirus outbreak |
| FY2021 | FY2023 | MIZUKAMI Takuo | National Institute of Infectious Diseases | Section Chief | Research and Development of a Hyperimmune Globulin Product against Mother-to-Child Transmission of HTLV-1 |
| FY2021 | FY2023 | SUGAI Motoyuki | National Institute of Infectious Diseases | Director | Studies on strengthening the AMR surveillance and the comprehensive promotion of countermeasures to AMR |
| FY2021 | FY2023 | OHNISHI Makoto | National Institute of Infectious Diseases | Deputy Director General | Study of Antimicrobial resistance of Neisseria gonorrhoeae and Mycoplasma genitalium infections. |
| FY2021 | FY2023 | KOMATSUZAWA Hitoshi | Hiroshima University | Professor | Study of the inhibition of colonization of drug-resistant bacteria in the oral cavity and upper respiratory tract. |
| FY2021 | FY2023 | MITARAI Satoshi | Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association | Professor/Head | A comprehensive basic study against difficult factors for tuberculosis control |
| FY2021 | FY2023 | HOSHINO Yoshihiko | National Institute of Infectious Diseases | Division Chief | The development of novel treatment strategy regarding mechanism of latency and re-activation of mycobacterial infection using epidemiological observation |
| FY2021 | FY2023 | OKADA Masaji | National Hospital Organization, Kinki-chuo Chest Medical Center | Visiting Senior Scientist | Study of a therapy (A Novel Therapeutic Vaccine) against tuberculosis and diagnosis for latent tuberculosis infection |
| FY2021 | FY2023 | MIYAZAKI Yoshitsugu | National Institute of Infectious Diseases | Director-General, Director | Study of leprosy toward elimination and control |
| FY2021 | FY2023 | IYODA Sunao | National Institute of Infectious Diseases | Chief | Research for the establishment of surveillance and virulence evaluation methods of diarrheagenic bacterial pathogen derived from severe cases |
| FY2021 | FY2023 | SUZUKI Motoi | National Institute of Infectious Diseases | Director | Research on surveillance for vaccine-preventable diseases and the evaluation of vaccine effectiveness |
| FY2021 | FY2023 | KASAI Shinji | National Institute of Infectious Diseases | Director of the Department | Studies on the arthropod vectors that transmit infectious diseases |
| FY2021 | FY2023 | ANDO Shuji | National Institute of Infectious Diseases | Chief | Comprehensive study for tick-borne infectious diseases |
| FY2021 | FY2023 | MAEDA Ken | National Institute of Infectious Diseases | Director | Comprehensive studies on countermeasure to companion animal-borne diseases |
| FY2021 | FY2023 | KUROSAKI Yohei | Nagasaki University | Associate Professor | Study of practical biorisk management in the microbiological containment laboratories |
| FY2021 | FY2023 | FUKUHARA Takasuke | Hokkaido University | Professor | Establishment of novel high-speed reverse genetics system for all RNA viruses |
| FY2021 | FY2023 | OGURA Yoshitoshi | Kurume University School of Medicine | Professor | Development of new therapeutic and preventive strategy for Clostridioides difficile infection |
| FY2021 | FY2023 | UEMATSU Satoshi | Osaka City University | Professor | Development of innovative phage therapy based on comprehensive metagenomic analysis |
| FY2021 | FY2023 | UCHIDA Satoshi | Kyoto Prefectural University of Medicine | Associate Professor | Development of mRNA nano-vaccines possessing double-stranded RNA in mRNA side chains for pandemics |
| FY2021 | FY2023 | NAMKOONG Ho | Keio University School of Medicine | Associate Professor | Elucidation of pathogenesis of NTM pulmonary disease based on integrated analysis of host and pathogen genomes |
| FY2021 | FY2023 | MISAWA Takashi | National Institute of Health Sciences | Cheif | Study of middle-size drugs for multi-drug resistance bacteria |
| FY2021 | FY2023 | KATOH Hiroshi | National Institute of Infectious Diseases | Chief | Elucidation of the neurotropic mechanism of mumps virus by identification of receptor glycans and its application to therapy |
09/01/22
Last updated 09/01/22